Skip to main content
EJNMMI Research
Figure 4 | EJNMMI Research

Figure 4

From: Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignancies

Figure 4

Correlation between reduction in tumour perfusion and clinical benefit, duration of therapy, and FDG-SUV change. Potential correlations between percent reduction in tumour perfusion and clinical benefit (p = 0.05) (a), duration of therapy (p = 0.05) (b), and percent reduction in FDG-SUV (p > 0.05) (c).

Back to article page